jRCT1070250117尚未招募不适用
Evaluation of the Efficacy, Safety, and Patient Self-Assessment in Reducing Downtime by Use of Membrane Formation Collagen Hydrogel Following Ablative CO2 Fractional Laser Resurfacing
未提供0 个研究点目标入组 5 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
- 分配方式
- Single Arm Study
入排标准
- 年龄范围
- 20age old over 至 60age old under（—）
- 性别
- All
入选标准
- •Healthy Asian people aged 20~
- •Skin type: 3-4
- •Someone is available in this study's schedule.
- •Someone who is less revealed in sunlight during the observational period.
- •Someone who can accept researchers' orders.
排除标准
- •Someone who has received the facial treatment for aesthetic purposes within 90 days before this study.
- •Chemical Sensitivity, especially alcoholic sensitivity.
- •Someone subject to the contraindication of Ablative CO2 Fractional Laser Resurfacing.
- •Someone whom the researcher considers not appropriate for this study.
研究者
相似试验
招募中
1 期
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.2025-522243-17-00Philogen S.p.A.96
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
已完成
2 期
A study to investigate safety and efficacy with SAR445514 in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refractory light-chain amyloidosis (RRLCA)2022-502057-33-00Sanofi-Aventis Recherche & Developpement59
招募中
1 期
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112
招募中
1 期
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.2025-523587-20-00Gruenenthal GmbH24